Austrian Institute for Health Technology Assessment (AIHTA), Vienna, Austria.
Austrian Health Insurance Fund (ÖGK), St. Pölten, Austria.
Eur J Cancer Care (Engl). 2021 Jul;30(4):e13423. doi: 10.1111/ecc.13423. Epub 2021 Feb 7.
Since end-of-life care (EOL) is an internationally accepted indicator for the quality of oncological care we aimed to investigate the current EOL care situation for Austrian cancer patients especially concerning the place of death cancer treatment hospitalisation near death and palliative care.
A retrospective data analysis was carried out based on Austrian routine inpatient data of the years 2012 to 2016. Data including the date of death of adult patients with a main hospital discharge diagnosis of a neoplasm were included. All analyses were source-related and based on the place of residence.
In total 80818 cancer patients have died between 2012 and 2016 of whom 53.4% died in the inpatient setting. Palliative care at the EOL (last hospitalisation) was present in 12.9% of patients whereby more than 50% were admitted two to 14 days before death. Considering cancer treatment at the EOL (30 days before death) 6.9% of cancer patients have received chemotherapy 1.7% radiation therapy and 0.75% were treated with a monoclonal antibody.
In international comparison Austria appears to do well on quality indicators concerning ICU-admission and chemotherapy treatment average on hospital death and poorly on hospital admissions and timely referral for palliative care.
由于临终关怀（EOL）是肿瘤护理质量的国际公认指标，我们旨在调查奥地利癌症患者的临终关怀现状，特别是临终关怀的死亡地点、癌症治疗住院、临近死亡和姑息治疗。
基于 2012 年至 2016 年奥地利常规住院数据进行回顾性数据分析。数据包括患有主要诊断为恶性肿瘤的成年患者的死亡日期。所有分析均与来源相关，并基于居住地。
2012 年至 2016 年间，共有 80818 名癌症患者死亡，其中 53.4%在住院期间死亡。临终关怀（最后一次住院）中有 12.9%的患者接受姑息治疗，其中超过 50%的患者在死亡前 2 至 14 天入院。考虑到临终时的癌症治疗（死亡前 30 天），有 6.9%的癌症患者接受了化疗，1.7%接受了放疗，0.75%接受了单克隆抗体治疗。
与国际比较，奥地利在 ICU 入院和化疗治疗等质量指标方面表现良好，平均在医院死亡，在医院入院和及时转介姑息治疗方面表现不佳。
